Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "zts"

Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO

Ackman's Selling, But This Company May Still Be a Buy

Zoetis Inc. (NYSE: ZTS) is the globe's biggest animal health company, and its sales and profit are benefiting from tailwinds that are supporting market growth, including an expanding population and increasing global wealth. Nevertheless, billionaire ..., 4 days ago
Zoetis' CFO leaves company to join Valeant - DJ Seeking Alpha, 1 month ago

Zoetis Capitalizing On Lack Of Competition In Generic Animal Drug Competition

Argus Jacob Kilstein believes Zoetis Inc (NYSE: ZTS ) has been benefiting from a lack of generic competition in the animal drug space. Kilstein maintains a Buy rating on the company, while raising the price target from $54 to $58. Benefiting ...
 Benzinga.com2 weeks ago

Thursday 9/8 Insider Buying Report: ZTS, COO

 Forbes.com2 weeks ago

Top Buys by Directors: McCallister's $102.7K Bet on ZTS

 Forbes.com2 weeks ago

Zoetis: A Growth Company That Is Poised For Long-Term Success

Background According to Zoetis' (NYSE: ZTS ) website , they discover, develop, manufacture and commercialize a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock ...
 Seeking Alpha2 weeks ago
Motley Fool

Pet Spending Is Soaring -- Should You Buy Zoetis Inc.?

Image source: . Zoetis Inc. ( NYSE:ZTS ) is the world's biggest pure-play manufacturer of healthcare products used in animals. The company's livestock and companion animal product lines and its global footprint means that it's positioned to ...
 Motley Fool3 weeks ago

Valeant's New CFO Is An Excellent Hire

Valeant (NYSE: VRX ) made a crucial move Monday, hiring rockstar CFO Paul Herendeen from Zoetis (NYSE: ZTS ). The hiring decision, likely a product of Bill Ackman's investment in Zoetis, is the absolute perfect choice for Valeant. Outgoing CFO ...
 Seeking Alpha1 month ago Startups pitch health-monitoring ear tags as cost-savers  FiercePharma3 days ago Cattlemen Test High-Tech Ear Tags to Monitor Animal Health  ADVFN India6 days ago Valeant Hiring Paul Herendeen as New CFO  ADVFN India1 month ago

Zoetis (ZTS) Juan Ramón Alaix on Q2 2016 Results - Earnings Call Transcript

Zoetis, Inc. (NYSE: ZTS ) Q2 2016 Earnings Call August 03, 2016 8:30 am ET Executives Steve Frank - Investor Relations, Zoetis, Inc. Juan Ramón Alaix - President, Chief Executive Officer & Director Paul S. Herendeen - Chief ...
 Seeking Alpha1 month ago Jefferies Group Weighs in on Zoetis Inc.'s Q2 2016 Earnings (ZTS)  WKRB News2 months ago Zoetis Inc. (ZTS) to Post Q2 2016 Earnings of $0.45 Per Share, Jefferies Group Forecasts  SleekMoney2 months ago

Zoetis (ZTS) Beats on Q2 Earnings & Revenues, Lifts Outlook

Zoetis Inc. 's ZTS second-quarter 2016 earnings of 49 cents per share came in above the Zacks Consensus Estimate of 44 cents. Earnings also increased 14% from the year-ago period. Zoetis Inc. (ZTS) Street EPS & Surprise Percent - Last 5 Quarters ...
 Yahoo! Finance1 month ago

Zoetis revenues up 3%; Non-GAAP EPS up 14% in Q2; updates guidance

Zoetis ( ZTS +0.04%) Q2 results : Revenues: $1,208M (+2.8%); Net Income: $224M; EPS: $0.45; Non-GAAP EPS: $0.49 (+14.0%). 2016 Guidance : Revenue: $4,800M - 4,900M; Adjusted SG&A Expenses: $1,290M - 1,330M; Adjusted R&D Expenses: $360M - 380M; ...
 Seeking Alpha1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less